Novant Health Strategic Investments

Profile and portfolio

Parent Novant Health

Novant Health Strategic Investments is the corporate venture arm of Novant Health, a healthcare company. It invests from Series A to Series B. Sectors it names: healthcare and digital health.

Every figure links to its source

Snapshot

Investment stage: Series A to Series B

Data behind this graphic

Data behind this graphic
Item	Value
Stage range	Series A to Series B
Sectors	Healthcare and digital health
Geography	North America

Sources: S1 Fierce Healthcare: Advocate Aurora, Novant Health and Stanford Health Care back Xealth USD 24M round.

Where it invests

Geography

Investment regionsS1

North America

Key facts

Fact	Value	Status	Source
Parent company	Novant Health	Single source	S1
Parent industry	Healthcare and life sciences	Single source	S1
Status	Active	Single source	S1
Capital source	Parent company only	Single source	S1
Stages	Series A, Series B (inferred from announced rounds)	Estimate	S1

Portfolio

Public sources name 3 portfolio companies.S1

Shared portfolio with other corporate VCs

2 companies on the Novant Health Strategic Investments portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

Firm	Shared	Companies in common
Atrium Health Strategic Fund	1	Xealth
Advocate Aurora Enterprises	1	Xealth
Cone Health Ventures	1	Xealth
Froedtert Health Strategic Investments	1	Xealth
Nebraska Medicine Strategic Investments	1	Xealth
Stanford Health Care	1	Xealth
Trinity Health	1	Xealth
Accrete Health Partners	1	Truveta
CommonSpirit Ventures	1	Truveta
Ochsner Ventures	1	Truveta

Companies backed by the most corporate VCs

Every company on the Novant Health Strategic Investments list

3 companies, as named in the sources cited.S1 Read the firm's list.

Optain
Truveta
Xealth

Sources

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Novant Health Strategic Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.

Report a correction